Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07099599 · ClinicalTrials.gov registry record
Image Detection of Impaired Microcirculatory Reperfusion
A clinical trial of Large Vessel Occlusion and Ischemic Stroke, Acute, sponsored by University of Cincinnati.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT07099599 is a study of Large Vessel Occlusion and Ischemic Stroke, Acute that is actively recruiting participants, run by University of Cincinnati. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07099599, a study of Large Vessel Occlusion and Ischemic Stroke, Acute, is actively recruiting participants, sponsored by University of Cincinnati.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Stroke affects one patient every 40 seconds in the United States. It is most commonly caused by blood clots that develop in the blood vessels of the brain. These blood clots interrupt the normal flow of blood and oxygen to the nerve cells in the brain. When this occurs, the nerve cells can die, causing permanent damage to that area of the brain. That damage can result in loss of normal function to a patient's vision, strength, sensation, balance, or speech. These changes can remain permanent if blood flow is not restored to the brain. Thankfully, there are treatments available to help get rid of these blood clots. One of these treatments is a procedure to physically remove the blood clot causing stroke. This practice is now routinely done at all major stroke centers. Special imaging for stroke is now available at these major stroke centers. This imaging looks at blood flow in and around the area of brain that is dying. By performing these scans after the procedure, we can see that not all of brain is being saved by the procedure. That is a problem, because we know that saving brain cells can make a big difference in how patients recover from stroke. The purpose of this study is to determine which brain tissue will not get saved by blood clot removal. We will do this by using specialized imaging after the procedure. The study will discover if there is more brain tissue that can be saved after the procedure. Once we can determine this, our next steps will be looking at ways to save this tissue in the studies that follow. For example, we will look to see if medications can be given after the procedure to help save those brain areas. This study lays the groundwork for future studies to help save all the brain tissue we possibly can from dying during the stroke. This is our best chance of getting all patients affected by stroke the opportunity to live their best lives after stroke.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST CT Perfusion
Study Locations (1)
Ohio
- University of Cincinnati - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-09-30 |
| Est. Completion | 2027-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07099599
The ClinicalTrials.gov registry entry for NCT07099599 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Large Vessel Occlusion appearing as the primary indexed condition, and to 1 intervention - of which CT Perfusion is the first listed.
NCT07099599 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT07099599 about?
NCT07099599 is a clinical study titled "Image Detection of Impaired Microcirculatory Reperfusion". Stroke affects one patient every 40 seconds in the United States. It is most commonly caused by blood clots that develop in the blood vessels of the brain. These blood clots interrupt the normal flow of blood and oxygen to the nerve cells in the brain. When this occurs, the nerve cells can die, caus...
What is the current status of trial NCT07099599?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2024-09-30. Estimated completion is 2027-03-31.
What conditions does trial NCT07099599 study?
This clinical trial studies the following conditions: Large Vessel Occlusion, Ischemic Stroke, Acute.
What interventions are being tested in trial NCT07099599?
The interventions under investigation include: CT Perfusion (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07099599?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07099599 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Large Vessel Occlusion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.